Patrik Michel

Has grant

Associate Professor

Lausanne University Hospital
Country flagSwitzerland

Research Interests

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Explore related searches

Recent Grants

Grant: Close

Impact of qualitative MR perfusion imaging on the management of patients with carotid artery disease

Open Date: 2009-10-01

Close Date: 2016-09-30

Grant: Close

Stroke survival, recurrence and mortality in Tbilisi, Georgia: a population-based follow-up study

Open Date: 2005-09-01

Close Date: 2009-10-31

Articles (6)

Background Patent foramen ovale (PFO) closure is recommended for patients younger than 60 years with cryptogenic stroke, including embolic stroke of undetermined source (ESUS). However, the role of PFO closure in patients older than 60 years remains uncertain. We aim to investigate the benefits of PFO closure in young-older patients (aged between 60 and 70 years) with cryptogenic stroke. Methods Patients older than 60 years with cryptogenic stroke from large tertiary hospitals who received a PFO closure after a multidisciplinary brain-heart case conference, compared to an age-matched cohort of patients with cryptogenic stroke. Demographcis, vascular risk factors, and risk of paradoxical embolism (RoPE) score were collected for comparison between two groups. The primary outcome included recurrent ischemic stroke that occurred up to 5 years following PFO closure between the two groups. The safety outcome was the occurrence of any complications after PFO closure, including new-onset atrial fibrillation (AF). Results A total of 102 patients with cryptogenic stroke were included (mean age 66±4), 56 male (55%), who had a PFO closure. Procedure-related complications, including new onset transient AF, were low (1%). There was no statistical difference between two groups in patients demographic and clinical characteristics, but the RoPE score was significantly higher in the PFO closure group than in the control group. After a median follow-up of 54 months, patients in the PFO closure group demonstrated a relatively low incidence of recurrent ischemic stroke (3.9%, 4/102), compared to an age-matched control cohort with a median follow-up of 51 months, which had a higher recurrence rate (8.2%, 8/97). Conclusions In patients with cryptogenic stroke who are older than 60 years, PFO closure demonstrated safety profiles with a trend of reducing recurrent ischemic stroke compared to their age-matched counterparts. Prospective randomized trials are warranted in this young-older population with cryptogenic stroke and PFO.

Year:

2025

Background Acute ischemic stroke (AIS) can lead to profound disturbances in consciousness, including coma, which is associated with poor prognosis and increased mortality. Clarifying the lesion patterns that precipitate loss of consciousness can refine pathophysiological models and guide prognosis. Objectives In this study, we aim to identify the brain regions most commonly affected in comatose AIS and determine whether specific combinations of lesions are necessary and sufficient to produce coma. Methods We retrospectively analyzed 476 AIS patients (52 comatose) using diffusion-weighted imaging. Infarcts were automatically segmented, manually verified, and normalized to MNI space. Support vector regression lesion-symptom mapping (SVR-LSM) quantified voxel-wise associations with coma, controlling for lesion volume. To assess the necessity and sufficiency of lesion combinations, we employed permutation-based nested logistic regression models comparing all subsets of four anatomical predictors: brainstem, thalamus, cerebellum, and the rest of brain lesions. Results SVR-LSM revealed that coma was strongly associated with lesions involving the brainstem, thalamus, and cerebellum, whereas non-comatose patients exhibited predominantly cortical infarcts. Nested model comparisons showed that concurrent lesions to both the brainstem and thalamus were necessary and sufficient for coma. Additional involvement of the cerebellum or cerebral cortex did not improve predictive performance. Conclusions Coma after AIS results from a dual-node subcortical lesion pattern involving both the brainstem and thalamus. Cerebellar and cortical lesions, even when extensive, did not induce coma in the absence of the dual-brainstem and thalamic lesions. These observations emphasize the predominant role of lesion location over lesion volume in the pathogenesis of coma. They also support mechanistic models that position the brainstem and thalamic hubs as central to the neural circuitry underlying arousal. Furthermore, these findings delineate a specific anatomical substrate that may serve as a strategic target for circuit-based neuroprotective and neuromodulatory therapies.

Year:

2025

BACKGROUND Stroke treatment has significantly improved over the last decades, but the complexity of stroke cases requires specialized care through dedicated teams with specific knowledge and training. The National Institutes of Health Stroke Scale (NIHSS), widely used to assess neurological deficits and make treatment decisions, is reliable but requires specific training and certification. The traditional didactic training method, based on a video, may not adequately address certain NIHSS intricacies nor engage health care professionals (HCPs) in continuous learning, leading to suboptimal proficiency. In the context of time-constrained clinical settings, highly interactive e-learning could be a promising alternative for NIHSS knowledge acquisition and retention. OBJECTIVE This study aimed to assess the efficacy of a highly interactive e-learning module compared with a traditional didactic video in improving NIHSS knowledge among previously trained HCPs. Furthermore, its impact on knowledge retention was also assessed. METHODS A prospective, multicentric, triple-blind, and web-based randomized controlled trial was conducted in 3 Swiss university hospitals, involving HCPs previously trained in NIHSS. Invitations were sent through email, and participants were randomized to either the e-learning or traditional didactic video group through a fully automated process upon self-registration on the website. A 50-question quiz was administered before and after exposure to the training method, and scores were compared to assess knowledge acquisition. The quiz was repeated after 1 month to evaluate retention. Subjective assessments of learning methods that is, user satisfaction, probability of recommendation, perceived difficulty, and perception of duration, were also collected through a Likert-scale questionnaire. A sample size of 72 participants were deemed necessary to have an 80% chance of detecting a difference of 2 points in the postcourse quiz between groups at the 5% significance level. RESULTS Invitations to participate were sent through email to an estimated 325 HCPs. 174 HCPs enrolled in the study, of which 97 completed the study course. Both learning methods significantly improved NIHSS knowledge, with an improvement of 3.2 (range 2.0-4.3) points in the e-learning group and of 2.1 (1.2-3.1) points in the video group. However, the e-learning group performed better, with higher scores in knowledge acquisition (median score 39.0, IQR 36.0-41.0 vs 37, IQR 34.0-39.0; P =.03) and in knowledge retention (mean score 38.2, 95% CI 36.7-39.7 vs 35.8, 95% CI 34.8-36.8; P =.007). Participants in the e-learning group were more likely to recommend the learning method (77% vs 49%, P =.02), while no significant difference was found for satisfaction ( P =.17), perceived duration ( P =.17), and difficulty ( P =.32). CONCLUSIONS A highly interactive e-learning module was found to be an effective asynchronous method for NIHSS knowledge acquisition and retention in previously NIHSS-trained HCPs, and may now be considered for inclusion in NIHSS training programs for HCPs. CLINICALTRIAL INTERNATIONAL REGISTERED REPORT RR2-10.3390/healthcare9111460

Year:

2024

Background The efficacy and safety of statins for secondary prevention in patients who have experienced a cardioembolic stroke are not well-defined. However, previous observational data reported hyperlipidemia as a risk factor for both ischemic and bleeding complications in patients with AF and previous stroke. Based on these premises, we conducted a sub-analysis of the RAF and RAF-NOAC studies to evaluate the efficacy and safety of statins in secondary prevention in patients with acute ischemic stroke and AF. Methods We combined patient data from the RAF and RAF-NOAC studies, prospective observational studies conducted across Stroke Units in Europe, the United States, and Asia from January 2012 to June 2016. We included consecutive patients with AF who suffered an acute ischemic stroke with a follow-up of 90 days. Our outcomes were the combined endpoint, including stroke, transient ischemic attack, systemic embolism, symptomatic intracerebral hemorrhage, and major extracranial bleeding. Furthermore, both ischemic and hemorrhagic outcomes were evaluated separately. Results A total of 1.742 patients were included (46% male), and 898 (52%) received statins after the index event. At multivariable analysis, statin use was statistically associated with age (OR 0.92, 95% CI 0.97 - 0.99, p = 0.001), male sex (OR 1.35, 95% CI 1.07 - 1.70, p = 0.013), anticoagulation (OR 2.53, 95% CI 1.90 - 3.36, p <0.0001), hyperlipidemia (OR 5.52, 95% CI 4.28 - 7.12, p <0.0001), paroxysmal AF (OR 1.40, 95% CI 1.12 - 1.75, p = 0.003), leukoaraiosis (OR 1.39, 95% CI 1.11 - 1.75, p = 0.004) and heart failure (OR 0.72, 95% CI 0.53 - 0.98, p = 0.034). Statin use was not associated with the combined outcome event (OR 0,81, 95% CI 0,56 – 1,19, p = 0.286) and ischemic outcome event (OR 1,13, 95% CI 0,71 – 1,82, p = 0.604) while was associated with a lower risk of hemorrhagic outcome event (OR 0,49, 95% CI 0,27 – 0,88, p = 0.016). Conclusions Our data show that statins seem to protect against global bleeding events in cardioembolic stroke patients; this may be due to the pleiotropic effect of statins. More data are warranted to confirm these findings.

Year:

2024

Purpose Diffusion-weighted magnetic resonance imaging (DWI) is essential for diagnosing ischemic stroke and identifying targets for emergency revascularization. Apparent diffusion coefficient (ADC) maps derived from DWI are commonly used to locate the infarct core, but they are not strictly quantitative and can vary across platforms and sites due to technical factors. This retrospective study was conducted to examine how differences in ADC map generation, resulting from varied protocols across platforms and sites, affect the determination of infarct core size, location, and related clinical outcomes in acute stroke. Methods In this retrospective study, 726 acute anterior circulation stroke patients admitted to the Lausanne University Hospital between May 2018 and January 2021 were selected. DWI data were used to generate ADC maps as they would appear from different protocols: two simulated with low and medium angular resolution (4 and 12 diffusion gradient directions) and one with high angular resolution (20 directions). Using a DEFUSE like criteria and image post-processing, ischemic cores were localized; core volume, location, and associations to National Institutes of Health Stroke Scale (NIHSS) and modified Rankin Scale (mRS) scores were compared between the two imaging sequences. Results Significant differences were observed in the ADC distribution within white matter, particularly in the kurtosis and skewness, with the segmented infarct core volume being higher in protocols with reduced angular resolution compared to the 20-directions data (7.63 ml vs. 3.78 ml). The volumetric differences persisted after correcting for age, sex, and type of intervention. Infarcted voxels locations varied significantly between the two protocols. This variability affected associations between infarct core volume and clinical scores, with lower associations observed for 4-directions data compared to 20-directions data for NIHSS at admission and after 24 hours, and mRS after 3 months, further confirmed by multivariate regression. Conclusions Imaging protocol heterogeneity leads to significant changes in the ADC distribution, ischemic core location, size, and association with clinical scores. Work is needed in standardizing imaging protocols to improve the reliability of ADC as an imaging biomarker in stroke management.protocols to improve the reliability of ADC as an imaging biomarker in stroke management. Key Results Orientation changes in diffusion imaging significantly impact ADC distribution and threshold-based infarct core volume determination, affecting multi-centric studies. Lower number of directions in DWI acquisitions weakens associations between infarct volume measurements and clinical scores. Findings emphasize the impact of DWI acquisition protocol heterogeneity and image processing on acute stroke workups.

Year:

2024

One-fifth of strokes occur in the territory of the posterior circulation, but their management, particularly acute reperfusion therapy and neurointervention procedures for secondary prevention, has received much less attention than similar interventions for the anterior circulation. In this review, we overview the treatment of posterior circulation stroke, including both interventions in the acute setting and secondary prevention. We focus on areas in which the management of posterior circulation stroke differs from that of stroke in general and highlight recent advances. Effectiveness of acute revascularization of posterior circulation strokes remains in large parts unproven. Thrombolysis seems to have similar benefits and lower hemorrhage risks than in the anterior circulation. The recent ATTENTION and BAOCHE trials have demonstrated that thrombectomy benefits strokes with basilar artery occlusion, but its effect on other posterior occlusion sites remains uncertain. Ischemic and hemorrhagic space-occupying cerebellar strokes can benefit from decompressive craniectomy. Secondary prevention of posterior circulation strokes includes aggressive treatment of cerebrovascular risk factors with both drugs and lifestyle interventions and short-term dual anti-platelet therapy. Randomized controlled trial (RCT) data suggest basilar artery stenosis is better treated with medical therapy than stenting, which has a high peri-procedural risk. Limited data from RCTs in stenting for vertebral stenosis suggest that intracranial stenosis is currently best treated with medical therapy alone; the situation for extracranial stenosis is less clear where stenting for symptomatic stenosis is an option, particularly for recurrent symptoms; larger RCTs are required in this area.

Year:

2022

Collaborators (46)

Simona Sacco

Full Professor of Neurology - Head of the Clinical Neurology Unit

University of L'Aquila

ITALY
View details

Danilo Toni

Full Professor of Neurology

Sapienza University

ITALY
View details

Alessandro Pezzini

Associate Professor of Neurology

University of Parma

ITALY
View details

Walter Ageno

Associate Professor

University of Insubria

ITALY
View details

Davide Strambo

-

SWITZERLAND
View details

George Ntaios

Professor of Internal Medicine

University of Thessaly

GREECE
View details

Sung Il Sohn

Professor

Keimyung University Dongsan Medical Center

SOUTH KOREA
View details

Theodoros Karapanayiotides

Associate Professor

Aristotle University of Thessaloniki

GREECE
View details

Georgios Tsivgoulis

-

UNITED STATES
View details

Piergiorgio Lochner

Head of Neurointensive Care Unit Unit and Neurosonology Lab

Saarland University

GERMANY
View details

Eugenia Rota

Chief

-

ITALY
View details

Jukka Putaala

-

FINLAND
View details

Maria Kosmidou

Ass Professor

Aristotle University of Thessaloniki

GREECE
View details

Brian Mac Grory

Assistant Professor

Duke University School of Medicine

UNITED STATES
View details

Azmil H Abdul-Rahim

University of Glasgow

UNITED KINGDOM
View details

Gian Marco De Marchis

Head of Personal Board

University Hospital Basel

SWITZERLAND
View details

MARINA DIOMEDI

Associate Professor, Tor Vergata University

University of Rome Tor Vergata

ITALY
View details

Laetitia Yperzeele

Antwerp University Hospital

BELGIUM
View details

Laurent Suppan

University Hospital of Geneva

SWITZERLAND
View details

Leonardo Pantoni

-

ITALY
View details

Thibaut Desmettre

Head of Department of Acute Medicine

University Hospital of Geneva

SWITZERLAND
View details

Maarten G. Lansberg

Professor

Stanford University

UNITED STATES
View details

Stefan Engelter

Chair Department Rehabilitation & Neurology and Head of Stroke Treatment Pathyway

-

SWITZERLAND
View details

Sotirios Giannopoulos

Professor fo Neurology

National and Kapodistrian University of Athens

GREECE
View details

Lina Palaiodimou

National and Kapodistrian University of Athens

GREECE
View details

Jesse Dawson

Professor of Stroke Medicine

University of Glasgow

UNITED KINGDOM
View details

Yuriy Flomin

Professor

ukraine; shupyk national healthcare university of ukraine

UKRAINE
View details

Turgut Tatlisumak

Professor

Göteborgs Universitet

SWEDEN
View details

Isabella Canavero

Fondazione IRCCS Istituto Neurologico Carlo Besta

ITALY
View details

Daniel Strbian

-

FINLAND
View details

Mélanie Suppan

University of Geneva

SWITZERLAND
View details

Emmanuel Carrera

University of Geneva

SWITZERLAND
View details

Avinash Koka

University Hospital of Geneva

SWITZERLAND
View details

PANAGIOTIS HALVATSIOTIS

Associate Professor

National and Kapodistrian University of Athens - Faculty of Medicine

GREECE
View details

Brian Edlow

Vice Chair of Research

Massachusetts General Hospital

UNITED STATES
View details

Jonas Richiardi

Lausanne University Hospital

SWITZERLAND
View details

Maurizio Paciaroni

Docenti di ruolo di IIa fascia

University of Ferrara

ITALY
View details

Konstantinos Vadikolias

Professor

Democritus University of Thrace

GREECE
View details

Maurizio Acampa

University of Siena

ITALY
View details

PIERLUIGI BERTORA

Assistant professor

Università degli Studi di Torino

ITALY
View details

David Seiffge

-

SWITZERLAND
View details

Andrea Morotti

-

ITALY
View details

guillaume saliou

Professor

-

SWITZERLAND
View details

Alexandros Polymeris

Attending Neurologist

University Hospital Basel

SWITZERLAND
View details

Manuel Cappellari

-

ITALY
View details

Richard McKinley

Research Director

University Hospital of Bern

SWITZERLAND
View details